A. Camera

Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

F. Locatelli, M. Andreani, L. Moretta, 2019, Leukemia.

Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?

G. Del Baldo, Iside Alessi, A. Carai, 2021, Frontiers in Immunology.

Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts

A. Órfão, P. Marcatili, F. Locatelli, 2021, Journal for ImmunoTherapy of Cancer.

CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T cells

M. Scarsella, M. Tartaglia, I. Caruana, 2020, Haematologica.

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape

C. Sorino, M. Fanciulli, I. Caruana, 2021, Journal for ImmunoTherapy of Cancer.

Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma.

R. Hagedoorn, M. Heemskerk, E. Miele, 2018, Cancer research.

Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling

S. Campello, E. Papaleo, F. Cecconi, 2021, Acta Neuropathologica.

Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies

F. Locatelli, Sofia Reddel, I. Boffa, 2021, Frontiers in Immunology.